Magnolia NeuroSciences Company
Magnolia NeuroSciences discovers and develops drug-like small molecule therapeutics for the prevention of neuronal cell death.
Investors
Technology:
Neuropharmacology
Industry:
NeuroTech
Headquarters:
United States
Founded Date:
2018
Employees Number:
1-10
Funding Status:
N/A
Register and Claim Ownership